Caribou Biosciences Company Insiders

Caribou Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.2514) % which means that it has lost $0.2514 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.436) %, meaning that it created substantial loss on money invested by shareholders. Caribou Biosciences' management efficiency ratios could be used to measure how well Caribou Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.25 in 2024. Return On Capital Employed is likely to drop to -0.3 in 2024. Total Current Liabilities is likely to drop to about 23 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 296.2 M in 2024Common Stock Shares Outstanding is likely to drop to about 69.3 M in 2024. Net Loss is likely to drop to about (94 M) in 2024

Caribou Biosciences Workforce Comparison

Caribou Biosciences Insider Trading History

Caribou Biosciences Notable Stakeholders

The success or failure of an entity such as Caribou Biosciences often depends on how effective the management is. Caribou Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Caribou management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Caribou management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Caribou Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Caribou Biosciences. Check Caribou Biosciences' Beneish M Score to see the likelihood of Caribou Biosciences' management manipulating its earnings.

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.